These are top 10 stocks traded on the Robinhood UK platform in July
BOSTON - Specialty chemicals company Cabot Corporation (NYSE:CBT) reported fiscal first quarter earnings that topped analyst expectations, while revenue came in below estimates. The company also reaffirmed its full-year earnings guidance.
Cabot posted adjusted earnings per share of $1.76 for the quarter ended December 31, 2024, beating the analyst consensus of $1.74. Revenue was $955 million, falling short of Wall Street’s forecast of $995.43 million.
Compared to the same quarter last year, adjusted EPS increased 13% from $1.56, while revenue declined slightly from $958 million.
"We continued to execute against our Creating for Tomorrow strategy, delivering another quarter of strong results and in-line with our expectations," said Sean Keohane, Cabot’s President and CEO. "The Cabot team demonstrated operational excellence and agility in a challenging market environment."
The company’s Reinforcement Materials segment saw EBIT rise 1% year-over-year to $130 million, driven by volume growth in Asia Pacific and Europe, Middle East and Africa. Performance Chemicals segment EBIT jumped 32% to $45 million on improved volumes.
For fiscal year 2025, Cabot reaffirmed its adjusted EPS guidance range of $7.40 to $7.80, compared to the analyst consensus of $7.64.
The company generated operating cash flow of $124 million in Q1 and returned $66 million to shareholders through dividends and share repurchases. Cabot ended the quarter with approximately $1.3 billion in liquidity.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.